Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Bioxyne Limited ( (AU:BXN) ) is now available.
Bioxyne Limited has announced a consolidation of its securities, covering its ordinary fully paid shares, multiple series of options expiring in March 2027, and performance rights. The consolidation has a record date of 25 June 2026, with post-consolidation trading on a deferred settlement basis starting 24 June 2026 and new securities issued on 2 July 2026.
The move is part of a capital reorganisation that will restructure the company’s quoted equity and derivative instruments on the ASX. This consolidation is likely aimed at improving the structure and perceived value of Bioxyne’s securities, which can affect liquidity, pricing, and how the company is positioned and viewed in the capital markets by existing and prospective investors.
More about Bioxyne Limited
Bioxyne Limited is an ASX-listed company (code BXN) that issues ordinary fully paid shares, options with various exercise prices and expiries, and performance rights. The company operates within the listed equities market, providing investors with a range of equity and derivative securities linked to its underlying business activities.
Average Trading Volume: 4,595,267
Technical Sentiment Signal: Buy
Current Market Cap: A$173.4M
Find detailed analytics on BXN stock on TipRanks’ Stock Analysis page.